Groups divided by eGFR at baseline | |||||
---|---|---|---|---|---|
N† | All subjects | Normal eGFR | Low eGFR | P | |
(n = 130) | (n = 87) | (n = 43) | |||
Male subjects (%) | 130 | 72 | 71 | 74 | 0.71 |
Age (years) | 130 | 64 ± 12 | 61 ± 12 | 70 ± 10 | <0.01 |
Duration of diabetes (years) | 120 | 13 ± 9 | 11 ± 8 | 15 ± 10 | 0.03 |
Body weight (kg) | 124 | 74.0 ± 14.2 | 74.0 ± 14.8 | 73.9 ± 13.1 | 0.85 |
BMI (kg/m2) | 124 | 27.6 ± 4.8 | 27.6 ± 5.1 | 27.7 ± 4.4 | 0.78 |
Obesity (%)†† | 124 | 69 | 66 | 74 | 0.37 |
sBP (mmHg) | 122 | 135 ± 15 | 134 ± 12 | 139 ± 18 | 0.23 |
dBP (mmHg) | 119 | 80 ± 13 | 80 ± 13 | 79 ± 16 | 0.44 |
uPE (mg/dL) | 121 | 36 ± 77 | 21 ± 49 | 66 ± 109 | <0.01 |
Hematocrit (%) | 130 | 42.7 ± 4.1 | 42.6 ± 3.8 | 43.0 ± 4.6 | 0.63 |
Hemoglobin (g/L) | 130 | 143 ± 15 | 144 ± 14 | 142 ± 15 | 0.62 |
sUA (μmol/L) | 118 | 305 ± 70 | 297 ± 71 | 319 ± 67 | 0.12 |
Serum potassium (mEq/L) | 129 | 4.4 ± 0.4 | 4.4 ± 0.4 | 4.5 ± 0.4 | 0.05 |
HbA1c (%) | 129 | 8.4 ± 1.5 | 8.4 ± 1.6 | 8.3 1.4 | 0.83 |
HbA1c (mmol/mol) | 129 | 67.9 ± 16.5 | 68.2 ± 17.0 | 67.1 ± 15.5 | 0.83 |
eGFR (mL/min/1.73 m2) | 130 | 68.9 ± 21.8 | 80.7 ± 15.3 | 44.6 ± 10.4 | <0.01 |
Minimum, maximum | 23.1, 141.8 | 60.3, 141.8 | 23.1, 59.9 | ||
75th percentile, median, 25th percentile | 80.8, 70.0, 52.3 | 85.9, 77.3, 69.9 | 52.4, 46.2, 38.3 |
Groups divided by eGFR at baseline | |||||
---|---|---|---|---|---|
Normal-eGFR | Low-eGFR | P | |||
correlation coefficient | z | correlation coefficient | z | ||
Hematocrit | −0.14 | −0.14 | −0.39 | −0.41 | 0.16 |
Hemoglobin | −0.02 | −0.02 | −0.36 | −0.38 | 0.06 |
sBP | −0.45 | −0.48 | −0.57 | −0.65 | 0.41 |
uPE | −0.85 | −1.26 | −0.81 | −1.13 | 0.52 |
sUA | −0.46 | −0.50 | −0.63 | −0.74 | 0.22 |
HbA1c | −0.77 | −1.02 | −0.57 | −0.65 | 0.05 |
eGFR | −0.18 | −0.18 | 0.02 | 0.02 | 0.29 |